Sorrento Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SRNE and other ETFs, options, and stocks.

About SRNE

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. 

CEO
Henry H. Ji
CEOHenry H. Ji
Employees
799
Employees799
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1989
Founded1989
Employees
799
Employees799

SRNE Key Statistics

Market cap
706.42M
Market cap706.42M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
8.05M
Average volume8.05M
High today
$1.65
High today$1.65
Low today
$1.52
Low today$1.52
Open price
$1.65
Open price$1.65
Volume
6.51M
Volume6.51M
52 Week high
$7.79
52 Week high$7.79
52 Week low
$1.15
52 Week low$1.15

SRNE Earnings

-$0.57
-$0.30
-$0.03
$0.24
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 4, After Hours
ActualExpected Nov 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.